Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial
| Autor: | Dimopoulos, Meletios A *, Terpos, Evangelos, Boccadoro, Mario, Delimpasi, Sosana, Beksac, Meral, Katodritou, Eirini, Moreau, Philippe, Baldini, Luca, Symeonidis, Argiris, Bila, Jelena, Oriol, Albert, Mateos, Maria-Victoria, Einsele, Hermann, Orfanidis, Ioannis, Kampfenkel, Tobias, Liu, Weiping, Wang, Jianping, Kosh, Michele, Tran, NamPhuong, Carson, Robin, Sonneveld, Pieter |
|---|---|
| Zdroj: | In The Lancet Haematology October 2023 10(10):e813-e824 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|